Additional file 13 of An integrated prognosis model of pharmacogenomic gene signature and clinical information for diffuse large B-cell lymphoma patients following CHOP-like chemotherapy

Additional file 13: Table S9. Incremental values of pharmacogenomic factors when added to the clinical factors for overall survival.

附加文件13：表S9。针对总生存期（overall survival）分析，将药物基因组学因素（pharmacogenomic factors）纳入临床因素模型后，该类因素所产生的增量价值。